APA

Nickerson M. L., Das S., Im K. M., Turan S., Berndt S. I., Li H., Lou H., Brodie S. A., Billaud J. N., Zhang T., Bouk A. J., Butcher D., Wang Z., Sun L., Misner K., Tan W., Esnakula A., Esposito D., Huang W. Y., Hoover R. N., Tucker M. A., Keller J. R., Boland J., Brown K., Anderson S. K., Moore L. E., Isaacs W. B., Chanock S. J., Yeager M., Dean M. & Andresson T. (20170419). TET2 binds the androgen receptor and loss is associated with prostate cancer. : Oncogene.

Chicago

Nickerson M L, Das S, Im K M, Turan S, Berndt S I, Li H, Lou H, Brodie S A, Billaud J N, Zhang T, Bouk A J, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang W Y, Hoover R N, Tucker M A, Keller J R, Boland J, Brown K, Anderson S K, Moore L E, Isaacs W B, Chanock S J, Yeager M, Dean M and Andresson T. 20170419. TET2 binds the androgen receptor and loss is associated with prostate cancer. : Oncogene.

Harvard

Nickerson M. L., Das S., Im K. M., Turan S., Berndt S. I., Li H., Lou H., Brodie S. A., Billaud J. N., Zhang T., Bouk A. J., Butcher D., Wang Z., Sun L., Misner K., Tan W., Esnakula A., Esposito D., Huang W. Y., Hoover R. N., Tucker M. A., Keller J. R., Boland J., Brown K., Anderson S. K., Moore L. E., Isaacs W. B., Chanock S. J., Yeager M., Dean M. and Andresson T. (20170419). TET2 binds the androgen receptor and loss is associated with prostate cancer. : Oncogene.

MLA

Nickerson M L, Das S, Im K M, Turan S, Berndt S I, Li H, Lou H, Brodie S A, Billaud J N, Zhang T, Bouk A J, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang W Y, Hoover R N, Tucker M A, Keller J R, Boland J, Brown K, Anderson S K, Moore L E, Isaacs W B, Chanock S J, Yeager M, Dean M and Andresson T. TET2 binds the androgen receptor and loss is associated with prostate cancer. : Oncogene. 20170419.